Genomeweb’s PCR Insider – the global news source for PCR, sample prep and nucleic acid amplification – spoke with DNA Electronics CEO Chris Toumazou and CTO Leila Shepherd about their plans for pre-clinical pilot studies.
They described the Genalysis® system and their upcoming studies in pharmacogenetics with Dr Eric Topol and colleagues at the Scripps Research Institute in San Diego, and in infectious diseases at St Mary’s Hospital in London.
View the article (full access may be restricted to genomeweb subscribers)